Cytosine deaminase-uracil phosphoribosyltransferase and interleukin (IL)-12 and IL-18: a multimodal anticancer interface marked by specific modulation in serum cytokines. [electronic resource]
Producer: 20091022Description: 2323-34 p. digitalISSN:- 1078-0432
- Animals
- Apoptosis
- Cell Line, Tumor
- Cell Proliferation
- Combined Modality Therapy
- Cytokines -- blood
- Cytosine Deaminase -- genetics
- Flucytosine -- therapeutic use
- Interleukin-12 -- genetics
- Interleukin-18 -- genetics
- Lung Neoplasms -- secondary
- Lymphocytes, Tumor-Infiltrating -- immunology
- Male
- Mice
- Mice, Inbred C57BL
- Pentosyltransferases -- genetics
- Prodrugs -- therapeutic use
- Prostatic Neoplasms -- immunology
- Survival Analysis
- Th2 Cells -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.